Analysis of the prevalence of HIV resistant strains to antiretroviral drug in Privolzhsky Federal District

Zaĭtseva, N.N.; Parfenova, O.V.; Efimov, E.I.

Voprosy Virusologii 58(6): 39-41

2013


ISSN/ISBN: 0507-4088
PMID: 24772646
Document Number: 670109
Prevalence of the primary drug resistance mutations and resistance developed in patients receiving highly active antiretroviral therapies in the HIV-infected persons in the Privolzhsky federal district was studied. It was demonstrated that among the ART-naive HIV-positive patients there were no mutations leading to the development of resistance. A high level of the resistance to lamivudin, nevirapin, efavirenz was revealed among the persons receiving the antiretroviral therapy. As a whole, the frequency of mutations of resistance to nucleoside reverse transcriptase inhibitors (23.8%) and nonnucleoside reverse transcriptase inhibitors (26.9%) was much higher than to protease inhibitors (1.2%).

Document emailed within 1 workday
Secure & encrypted payments